| |
| |
|
| Insider
Information: |
Rowland Lloyd A |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
119,229 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$29,990 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
119,229 |
|
|
| Total
Value |
$29,990 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amylin Pharmaceuticals Inc |
AMLN |
VP, Chief Compliance O... |
2012-08-08 |
0 |
2012-08-08 |
0 |
Premium* |
|
|
Xencor Inc |
XNCR |
Sr. V.P. and General C... |
2015-12-15 |
1,501 |
2015-12-15 |
0 |
Premium* |
|
|
Cytomx Therapeutics, Inc. |
CTMX |
|
2024-03-19 |
117,728 |
2018-11-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CTMX |
Cytomx Therapeutics, Inc. |
General Counsel |
• • – |
2024-03-19 |
4 |
S |
$2.09 |
$10,986 |
D/D |
(5,268) |
117,728 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
General Counsel |
• • – |
2024-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
122,996 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
General Counsel |
• • – |
2023-12-20 |
4 |
S |
$1.38 |
$5,629 |
D/D |
(4,077) |
97,996 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
General Counsel |
• • – |
2023-12-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,250 |
102,073 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
General Counsel |
• • – |
2023-09-22 |
4 |
S |
$1.30 |
$7,135 |
D/D |
(5,486) |
80,609 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
General Counsel |
• • – |
2023-09-20 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
86,095 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
General Counsel |
• • – |
2023-03-16 |
4 |
S |
$1.98 |
$4,031 |
D/D |
(2,037) |
71,095 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
General Counsel |
• – – |
2023-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
73,132 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
General Counsel |
• – – |
2022-07-20 |
4 |
S |
$1.42 |
$7,968 |
D/D |
(5,602) |
43,689 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
General Counsel |
• – – |
2022-07-19 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
49,291 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
General Counsel |
• – – |
2022-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
22,500 |
34,291 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
General Counsel |
• – – |
2019-05-31 |
4 |
A |
$8.21 |
$14,878 |
D/D |
1,812 |
11,791 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
General Counsel |
• – – |
2019-03-04 |
4 |
B |
$10.33 |
$92,970 |
D/D |
9,000 |
9,979 |
2.74 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
General Counsel |
• – – |
2018-11-30 |
4 |
A |
$11.73 |
$11,484 |
D/D |
979 |
979 |
0 |
- |
|
| XNCR |
Xencor Inc |
Sr. V.P. and General Counsel |
• – – |
2015-12-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,501 |
1,501 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
VP, Chief Compliance Officer |
• – – |
2012-08-08 |
4 |
D |
$31.00 |
$360,821 |
I/I |
(11,639) |
0 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
VP, Chief Compliance Officer |
• – – |
2012-08-08 |
4 |
D |
$31.00 |
$1,098,212 |
D/D |
(35,426) |
0 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
VP, Chief Compliance Officer |
• – – |
2012-07-25 |
4 |
A |
$14.62 |
$12,032 |
D/D |
823 |
35,426 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
VP, Chief Compliance Officer |
• – – |
2012-03-29 |
4 |
AS |
$25.00 |
$75,000 |
D/D |
(3,000) |
34,603 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
VP, Chief Compliance Officer |
• – – |
2012-03-28 |
4 |
AS |
$22.83 |
$114,150 |
D/D |
(5,000) |
37,603 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
VP, Chief Compliance Officer |
• – – |
2012-03-28 |
4 |
OE |
$9.02 |
$45,100 |
D/D |
5,000 |
42,603 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
VP, Chief Compliance Officer |
• – – |
2012-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
6,700 |
37,603 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
VP, Chief Compliance Officer |
• – – |
2012-03-06 |
4 |
A |
$0.00 |
$0 |
I/I |
1,529 |
7,974 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
VP, Chief Compliance Officer |
• – – |
2012-03-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,767) |
30,903 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
VP, Chief Compliance OfficerVP |
• – – |
2012-02-08 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,000) |
32,009 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
